Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghasemali Divband

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Seminars in Nuclear Medicine|August 18, 2023
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET ImagingNasibeh Mohseninia, Nazanin Zamani-Siahkali, Sara Harsini, et al.
Clinical Nuclear Medicine|March 27, 2024
Complete Resolution of Locally Advanced Prostate Cancer After Molecular Endoradiotherapy With 177 Lu-PSMAMohsen Beheshti, Reza Vali, Soroush Zarehparvar Moghadam, et al.
Clinical Nuclear Medicine|June 4, 2024
First Experience of Radionuclide Therapy With 177Lu-FAPI-2286 in a Patient With Metastatic Mediastinal SarcomaSeyedeh Somayyeh Banihashemian, Mohadese Bayat, Elahe Pirayesh, et al.
Clinical Nuclear Medicine|November 6, 2024
Feasibility of Early 68 Ga-FAP-2286 PET Imaging: A Case StudySeyedeh Somayyeh Banihashemian, Ghasemali Divband, Abdolghafar Abolhosseini Shahrnoy, et al.
Clinical Genitourinary Cancer|January 31, 2026
Treatment Discontinuation in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Lutetium-177 (<sup>177</sup>Lu)-PSMA-617: A Retrospective Real-World StudyMohammad Hadi Samadi, Amirreza Shamshirgaran, Pegah Sahafi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 20, 2024
[<sup>68</sup>Ga]Ga-FAP-2286, a novel promising theragnostic approach for PET/CT imaging in patients with various type of metastatic cancersSeyedeh Somayyeh Banihashemian, Ghasemali Divband, Elahe Pirayesh, et al.
Seminars in Nuclear Medicine|January 3, 2024
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone MetastasesNazanin Zamani-Siahkali, Seyed Ali Mirshahvalad, Abolfazl Farbod, et al.
Journal of Clinical Medicine|August 19, 2020
Targeted Palliative Radionuclide Therapy for Metastatic Bone PainReyhaneh Manafi-Farid, Fardad Masoumi, Ghasemali Divband, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2024
Feasibility and therapeutic potential of [<sup>177</sup>Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcomaSeyedeh Somayyeh Banihashemian, Mohammad Esmaeil Akbari, Elahe Pirayesh, et al.
Nuklearmedizin. Nuclear Medicine|September 3, 2024
Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu-PSMA TherapyEsmail Jafari, Reyhaneh Manafi-Farid, Hojjat Ahmadzadehfar, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Seminars in Nuclear Medicine|August 18, 2023
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET ImagingNasibeh Mohseninia, Nazanin Zamani-Siahkali, Sara Harsini, et al.
Clinical Nuclear Medicine|March 27, 2024
Complete Resolution of Locally Advanced Prostate Cancer After Molecular Endoradiotherapy With 177 Lu-PSMAMohsen Beheshti, Reza Vali, Soroush Zarehparvar Moghadam, et al.
Clinical Nuclear Medicine|June 4, 2024
First Experience of Radionuclide Therapy With 177Lu-FAPI-2286 in a Patient With Metastatic Mediastinal SarcomaSeyedeh Somayyeh Banihashemian, Mohadese Bayat, Elahe Pirayesh, et al.
Clinical Nuclear Medicine|November 6, 2024
Feasibility of Early 68 Ga-FAP-2286 PET Imaging: A Case StudySeyedeh Somayyeh Banihashemian, Ghasemali Divband, Abdolghafar Abolhosseini Shahrnoy, et al.
Clinical Genitourinary Cancer|January 31, 2026
Treatment Discontinuation in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Lutetium-177 (<sup>177</sup>Lu)-PSMA-617: A Retrospective Real-World StudyMohammad Hadi Samadi, Amirreza Shamshirgaran, Pegah Sahafi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 20, 2024
[<sup>68</sup>Ga]Ga-FAP-2286, a novel promising theragnostic approach for PET/CT imaging in patients with various type of metastatic cancersSeyedeh Somayyeh Banihashemian, Ghasemali Divband, Elahe Pirayesh, et al.
Seminars in Nuclear Medicine|January 3, 2024
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone MetastasesNazanin Zamani-Siahkali, Seyed Ali Mirshahvalad, Abolfazl Farbod, et al.
Journal of Clinical Medicine|August 19, 2020
Targeted Palliative Radionuclide Therapy for Metastatic Bone PainReyhaneh Manafi-Farid, Fardad Masoumi, Ghasemali Divband, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2024
Feasibility and therapeutic potential of [<sup>177</sup>Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcomaSeyedeh Somayyeh Banihashemian, Mohammad Esmaeil Akbari, Elahe Pirayesh, et al.
Nuklearmedizin. Nuclear Medicine|September 3, 2024
Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu-PSMA TherapyEsmail Jafari, Reyhaneh Manafi-Farid, Hojjat Ahmadzadehfar, et al.
Pageof 4